November 23, 2017Annals of Oncology285 citationsOpen Access
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines
Key Points
Key points are not available for this paper at this time.
Abstract
Anaemia and iron deficiency (ID) are frequent complications in patients with solid tumours or haematological malignancies, particularly in patients treated with chemotherapeutic agents 1–3. Frequently, anaemia is associated with fatigue, impaired physical function and reduced quality of life (QoL) 4–7. Consequences of anaemia may include impaired response to cancer treatment and reduced overall survival (OS), even though a causal direct relationship has not yet been established 8, 9.